Search filters

List of works by James H. Herndon

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

scientific article published on 23 December 2016

A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma ⬇️

scientific article published on February 27, 2012

A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population

scientific article

A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma

scientific article published on 7 July 2011

A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

scientific article

A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma

scientific article

AT-19SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE.

scientific article

AT-20SINGLE INSTITUTION RETROSPECTIVE REVIEW OF PERFORMANCE STATUS AND CORTICOSTEROID USE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS (PTS) TREATED ON BEVACIZUMAB (BEV).

scientific article

AT-21FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM).

scientific article

ATCT-01PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG).

scientific article published on 9 November 2015

ATCT-13BEVACIZUMAB, RADIATION THERAPY (RT) AND TEMOZOLOMIDE FOLLOWED BY BEVACIZUMAB AND TEMOZOLOMIDE WITH CONTINUATION OF BEVACIZUMAB BEYOND PROGRESSION: A PHASE II TRIAL.

scientific article

Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme.

scientific article

Adjunctive perampanel for glioma-associated epilepsy

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

scientific article

Bevacizumab and daily temozolomide for recurrent glioblastoma

scientific article

Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas

scientific article published on November 2008

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

scientific article published in October 2007

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

scientific article

Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications

scientific article published on August 2004

Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial

scientific article published on 29 May 2013

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

scientific article

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine

scientific article

DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime

scientific article

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

scientific article

Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.

scientific article

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

scientific article

Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma

scientific article

Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial

scientific article

Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma

scientific article

Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge

article

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma ⬇️

scientific article published on December 10, 2010

IDH1 and IDH2 mutations in gliomas

scientific article

IMCT-19COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM).

scientific article

IT-34PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM).

scientific article published in November 2014

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma ⬇️

scientific article published on October 4, 2010

Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients

scientific article published on 13 August 2014

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

scientific article published on 10 April 2008

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

scientific article published on April 2017

Molecular markers of prognosis in astrocytic tumors

scientific article

Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans ⬇️

scientific article published on July 18, 2011

Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques

scientific article

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

scientific article

Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results

scientific article

ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN RECURRENT GLIOBLASTOMA (GBM): FIRST PHASE I CLINICAL TRIAL EVALUATING THE INTRATUMORAL ADMINISTRATION.

scientific article published in July 2014

ONCOLYTIC POLIOVIRUS IMMUNOTHERAPY OF GLIOBLASTOMA.

scientific article published in July 2014

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

scientific article

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

scientific article

Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma

scientific article published on 10 March 2012

Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma

scientific article

Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma

scientific article published on April 2004

Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma

scientific article

Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

scientific article

Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma

scientific article published on April 2004

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

scientific article

Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma

scientific article published on May 2009

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma

scientific article

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma

scientific article published in October 2005

Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma

scientific article

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

scientific article

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas

scientific article published on 21 December 2017

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma

scientific article published on 13 November 2017

Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.

scientific article

Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

scientific article published on 29 May 2015

Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

scientific article

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma

scientific article

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

scientific article published on 22 September 2011

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma

scientific article

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

scientific article

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

scientific article

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

scientific article

Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).

scientific article published on 6 June 2016

Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme

scientific article published on February 2009

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

scientific article

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

scientific article published in February 2007

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

scientific article published on May 2002

Phase II trial of gefitinib in recurrent glioblastoma

scientific article published on 24 November 2003

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas

scientific article published in March 2002

Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy

scientific article

Phase II trial of temozolomide in patients with progressive low-grade glioma

scientific article

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma

scientific article

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

scientific article published on 24 January 2013

Practical Dyspnea Assessment: Relationship Between the 0-10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity

scientific article published on 21 May 2015

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig

scientific article published in October 2003

QL-20PROGNOSTIC IMPORTANCE OF HEALTH-RELATED QUALITY OF LIFE AND FATIGUE IN NEWLY DIAGNOSED GLIOBLASTOMA.

scientific article published in November 2014

QL-21SPIRITUAL WELL-BEING AND ITS ASSOCIATION WITH HEALTH-RELATED QUALITY OF LIFE IN PRIMARY BRAIN TUMOR PATIENTS.

scientific article

QOL-19PROSPECTIVE EVALUATION OF CARDIOPULMONARY FITNESS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING AN ANTI-ANGIOGENIC REGIMEN.

scientific article

QOL-20LOW-DOSE NALTREXONE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA: PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED PILOT STUDY.

scientific article

QOL-21DIET AND HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN THE PRIMARY BRAIN TUMOR POPULATION.

scientific article

Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma

scientific article published in October 2006

RTRB-04STEREOTACTIC RADIOSURGERY FOR RECURRENT HIGH-GRADE GLIOMAS: PATIENT SELECTION AND THE ROLE OF BEVACIZUMAB.

scientific article published on 9 November 2015

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

scientific article

Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma

scientific article published on 21 March 2008

Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

scientific article published in January 2006

Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice

Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses.

scientific article

Survival analysis of presumptive prognostic markers among oligodendrogliomas.

scientific article published in October 2005

Temozolomide in children with progressive low-grade glioma

scientific article

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

scientific article published on 11 March 2015

The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma

scientific article

Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan

scientific article published on January 2008

Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects

scientific article

Paulina is supported by:

About Paulina

Help